S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
Log in

NASDAQ:ACERAcer Therapeutics Insider Trades

Add
Compare
Today's Range N/A
50-Day Range
$3.11
MA: $3.48
$4.47
52-Week Range N/A
Volume3.02 million shs
Average Volume511,425 shs
Market Capitalization$55.45 million
P/E RatioN/A
Dividend YieldN/A
Beta1.82

Insider Trades

Acer Therapeutics (NASDAQ:ACER) Insider Buying and Selling Activity

Insider Ownership Percentage: 20.10%

Insider Buying and Selling by Quarter


Acer Therapeutics (NASDAQ ACER) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/24/2020Chris SchellingCEOBuy142,857$3.50$499,999.501,892,857  
7/24/2020Donald JosephInsiderBuy14,285$3.50$49,997.5014,285  
7/24/2020Steve AselageDirectorBuy45,000$3.50$157,500.0063,905  
7/3/2019Steve AselageDirectorBuy5,000$3.72$18,600.00  
8/1/2018Life Science Ventures Vii TvmDirectorBuy275,000$18.00$4,950,000.00  
12/14/2017Steve AselageDirectorBuy2,000$12.00$24,000.00  
11/18/2016Timothy C BarabeDirectorSell14,914$0.55$8,202.7020,719  
9/17/2014Timothy C BarabeDirectorBuy10,000$1.15$11,500.00  
9/16/2014Neil K WarmaCEOBuy10,000$1.11$11,100.00  
12/18/2013Karthik RadhakrishnanCFOBuy8,000$1.70$13,600.00  
12/18/2013Scott B SeamanDirectorBuy30,000$1.70$51,000.00  
8/8/2013Karthik RadhakrishnanCFOBuy50,000$1.50$75,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.